Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues

J Am Acad Dermatol. 2012 Jan;66(1):e14-5. doi: 10.1016/j.jaad.2011.01.016.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aprepitant
  • Chronic Disease
  • Humans
  • Morpholines / therapeutic use*
  • Neurokinin-1 Receptor Antagonists
  • Pruritus / drug therapy*
  • Pruritus / etiology
  • Sezary Syndrome / complications

Substances

  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Aprepitant